This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Romain PL (2008) Access to clinical care via clinical trials: is it ethically possible? Nat Clin Pract Rheum 4: 166–167
Fleischmann R (2007) Primer: Establishing a clinical trial unit—obtaining studies and patients. Nat Clin Pract Rheum 3: 459–464
Fleischmann R (2007) Primer: establishing a clinical trial unit-regulations and infrastructure. Nat Clin Pract Rheum 3: 234–239
Author information
Authors and Affiliations
Ethics declarations
Competing interests
R Fleischmann declared that he is a consultant for, and has received research grants from Abbott, Amgen, Biogen Idec, Centocor, Genentech, Pfizer, Roche, UCB and Wyeth. R Fleischmann is also a consultant for AstraZeneca, a stock-holder/director for Abbott and AstraZeneca, and has received speakers bureau from Abbott, Amgen and Wyeth.
Rights and permissions
About this article
Cite this article
Fleischmann, R. Clinical studies can be performed in an ethical manner. Nat Rev Rheumatol 4, E5 (2008). https://doi.org/10.1038/ncprheum0856
Issue date:
DOI: https://doi.org/10.1038/ncprheum0856
This article is cited by
-
Author response to “Clinical studies can be performed in an ethical manner”
Nature Clinical Practice Rheumatology (2008)